(SLGN) Silgan Holdings - Ratings and Ratios
Dispensing Closures, Metal Containers, Custom Plastic, Thermoformed Trays
Dividends
| Dividend Yield | 2.08% |
| Yield on Cost 5y | 2.44% |
| Yield CAGR 5y | 12.17% |
| Payout Consistency | 54.3% |
| Payout Ratio | 20.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.0% |
| Value at Risk 5%th | 38.8% |
| Relative Tail Risk | -9.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.18 |
| Alpha | -41.32 |
| CAGR/Max DD | -0.25 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.227 |
| Beta | 0.650 |
| Beta Downside | 0.561 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.70% |
| Mean DD | 12.82% |
| Median DD | 13.06% |
Description: SLGN Silgan Holdings November 05, 2025
Silgan Holdings Inc. (NYSE: SLGN) manufactures rigid packaging for consumer goods, operating in the United States and abroad through three business segments: Dispensing & Specialty Closures, Metal Containers, and Custom Containers.
The Dispensing & Specialty Closures segment supplies proprietary metal and plastic closures, capping equipment, and fragrance-detection systems for markets such as beauty, food, beverage, and health care. The Metal Containers segment produces steel and aluminum cans for food processors (e.g., pet food, soups, proteins) and general-line promotional cans. The Custom Containers segment offers high-density polyethylene (HDPE) and PET containers, thermo-formed bowls, and trays for shelf-stable foods, as well as plastic caps and fitments.
Silgan reaches customers primarily via a direct sales force, a network of distributors, and an online catalog, leveraging its integrated packaging solutions to lock in multi-product contracts with major CPG manufacturers.
Key performance indicators from the most recent fiscal year show revenue of approximately $2.1 billion, an adjusted EBITDA margin near 8 %, and a capital-intensity ratio of 0.45, indicating moderate leverage. The business is sensitive to aluminum and steel price volatility, which have risen 12 % year-over-year, and to consumer-packaged-goods demand trends-particularly the continued shift toward single-serve and on-the-go formats that boost closure and metal-can volumes.
For a deeper, data-driven assessment of Silgan’s valuation dynamics and scenario analysis, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (339.6m TTM) > 0 and > 6% of Revenue (6% = 413.7m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -1.46pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 9.59% (prev 3.70%; Δ 5.90pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 934.1m > Net Income 339.6m (YES >=105%, WARN >=100%) |
| Net Debt (4.56b) to EBITDA (661.9m) ratio: 6.89 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (105.7m) change vs 12m ago -1.37% (target <= -2.0% for YES) |
| Gross Margin 16.88% (prev 17.14%; Δ -0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.97% (prev 74.65%; Δ 5.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.25 (EBITDA TTM 661.9m / Interest Expense TTM 187.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.55
| (A) 0.07 = (Total Current Assets 3.11b - Total Current Liabilities 2.45b) / Total Assets 9.50b |
| (B) 0.38 = Retained Earnings (Balance) 3.61b / Total Assets 9.50b |
| (C) 0.05 = EBIT TTM 422.4m / Avg Total Assets 8.62b |
| (D) 0.50 = Book Value of Equity 3.61b / Total Liabilities 7.23b |
| Total Rating: 2.55 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.06
| 1. Piotroski 3.0pt |
| 2. FCF Yield 7.67% |
| 3. FCF Margin 9.00% |
| 4. Debt/Equity 1.92 |
| 5. Debt/Ebitda 6.89 |
| 6. ROIC - WACC (= 0.15)% |
| 7. RoE 15.86% |
| 8. Rev. Trend 29.68% |
| 9. EPS Trend 17.09% |
What is the price of SLGN shares?
Over the past week, the price has changed by -2.41%, over one month by +1.22%, over three months by -13.82% and over the past year by -30.07%.
Is SLGN a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SLGN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.6 | 29.3% |
| Analysts Target Price | 49.6 | 29.3% |
| ValueRay Target Price | 33.2 | -13.5% |
SLGN Fundamental Data Overview November 26, 2025
P/E Trailing = 13.0918
P/E Forward = 10.1833
P/S = 0.6409
P/B = 1.8465
P/EG = 0.8384
Beta = 0.74
Revenue TTM = 6.90b USD
EBIT TTM = 422.4m USD
EBITDA TTM = 661.9m USD
Long Term Debt = 3.81b USD (from longTermDebt, last quarter)
Short Term Debt = 1.13b USD (from shortLongTermDebt, last quarter)
Debt = 4.36b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 4.56b USD (from netDebt column, last quarter)
Enterprise Value = 8.09b USD (4.12b + Debt 4.36b - CCE 389.2m)
Interest Coverage Ratio = 2.25 (Ebit TTM 422.4m / Interest Expense TTM 187.4m)
FCF Yield = 7.67% (FCF TTM 620.3m / Enterprise Value 8.09b)
FCF Margin = 9.00% (FCF TTM 620.3m / Revenue TTM 6.90b)
Net Margin = 4.93% (Net Income TTM 339.6m / Revenue TTM 6.90b)
Gross Margin = 16.88% ((Revenue TTM 6.90b - Cost of Revenue TTM 5.73b) / Revenue TTM)
Gross Margin QoQ = 16.29% (prev 16.29%)
Tobins Q-Ratio = 0.85 (Enterprise Value 8.09b / Total Assets 9.50b)
Interest Expense / Debt = 1.15% (Interest Expense 50.0m / Debt 4.36b)
Taxrate = 24.32% (36.2m / 148.7m)
NOPAT = 319.7m (EBIT 422.4m * (1 - 24.32%))
Current Ratio = 1.27 (Total Current Assets 3.11b / Total Current Liabilities 2.45b)
Debt / Equity = 1.92 (Debt 4.36b / totalStockholderEquity, last quarter 2.27b)
Debt / EBITDA = 6.89 (Net Debt 4.56b / EBITDA 661.9m)
Debt / FCF = 7.35 (Net Debt 4.56b / FCF TTM 620.3m)
Total Stockholder Equity = 2.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.58% (Net Income 339.6m / Total Assets 9.50b)
RoE = 15.86% (Net Income TTM 339.6m / Total Stockholder Equity 2.14b)
RoCE = 7.09% (EBIT 422.4m / Capital Employed (Equity 2.14b + L.T.Debt 3.81b))
RoIC = 4.68% (NOPAT 319.7m / Invested Capital 6.83b)
WACC = 4.53% (E(4.12b)/V(8.48b) * Re(8.41%) + D(4.36b)/V(8.48b) * Rd(1.15%) * (1-Tc(0.24)))
Discount Rate = 8.41% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.58%
[DCF Debug] Terminal Value 78.00% ; FCFE base≈619.9m ; Y1≈664.7m ; Y5≈810.7m
Fair Price DCF = 125.1 (DCF Value 13.21b / Shares Outstanding 105.7m; 5y FCF grow 8.09% → 3.0% )
EPS Correlation: 17.09 | EPS CAGR: 12.29% | SUE: 0.0 | # QB: 0
Revenue Correlation: 29.68 | Revenue CAGR: 9.30% | SUE: 0.41 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=-0.066 | Revisions Net=-6 | Analysts=8
EPS next Year (2026-12-31): EPS=3.86 | Chg30d=-0.398 | Revisions Net=-10 | Growth EPS=+4.8% | Growth Revenue=+2.2%
Additional Sources for SLGN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle